Harvey L. Sharp – 1 August 1995

Yutaka Inagaki, Sharada Truter, Patricia Greenwel, Marcos Rojkind, Masashi Unoura, Kenichi Kobayashi, Francesco Ramirez – 1 August 1995 – Fat‐storing cells (FSC) are the main producers of type I collagen in both normal and fibrotic livers. In order to elucidate the molecular mechanisms controlling collagen expression in FSC, we examined the transcription of the α2(I) collagen gene (COL1A2) in two distinct FSC clones, CFSC‐2G and CFSC‐5H, derived from a single CCl4‐induced cirrhotic liver.

Laurie C. Miller, Archna Sharma, Augusta F. McKusick, Joseph P. Tassoni, Charles A. Dinarello, Marshall M. Kaplan – 1 August 1995 – Primary biliary cirrhosis (PBC) is a chronic, progressive, cholestatic liver disease. Interleukin‐1β (IL‐1β) may play a role in the pathogenesis of PBC by contributing to altered immune function and fibrosis. Colchicine or methotrexate has some beneficial effects in the treatment of PBC, and also affects interleukin‐1 (IL‐1).

Gin‐Ho Lo, Kwok‐Hung Lai, Jing‐Shiung Cheng, Jia‐Huey Hwu, Chia‐Fu Chang, Sam‐Ming Chen, Hung‐Ting Chiang – 1 August 1995 – We conducted a prospective, randomized trial comparing sclerotherapy and ligation in 120 patients with acute bleeding of esophageal varices. All the patients were cirrhotic, 59 received sclerotherapy, and 61 received ligation. Treatment was repeated regularly until the varices were obliterated. The mean follow‐up period was 295 ± 120 days and 310 ± 105 days for the sclerotherapy and ligation groups, respectively.

Shunji Narumi, John P. Roberts, Jean C. Emond, John Lake, Nancy L. Ascher – 1 August 1995 – The clinical course of 37 patients who underwent 46 liver transplantations for primary (n = 33) and secondary (n = 4) sclerosing cholangitis was reviewed. The median follow‐up was 37 months. The patient and graft survivals for patients with primary sclerosing cholangitis at 1, 2, and 5 years were 96.9%, 91.6%, 87.9%, and 83.1%, 74.2%, 65.2%, respectively.

Bruno Turlin, Frédéric Juguet, Romain Moirand, Danielle Le Quilleuc, Olivier Loréal, Jean‐Pierre Campion, Bernard Launois, Marie‐Paule Ramée, Pierre Brissot, Yves Deugnier – 1 August 1995 – Iron was systematically studied in the nontumorous liver of 24 patients with hepatocellular carcinoma (HCC) developed on a noncirrhotic liver compared with 4 control groups (cirrhosis with and without HCC, liver metastasis, and normal liver) matched according to age, sex, and presence of chronic alcoholism.

Anne‐Marie Steffan, Carlos Augusto Pereira, Annick Bingen, Michele Valle, Jean‐Pierre Martin, Françoise Koehren, Cathy Royer, Jean‐Louis Gendrault, André Kirn – 1 August 1995 – Fenestrations of hepatic endothelial cells play an active role as a sieving barrier allowing extensive exchange between the blood and liver parenchyma. Alteraction of these structures may be induced in the course of various pathological events and provoke important perturbations of liver function.

Masafumi Naito, Norio Hayashi, Toyoki Moribe, Hideki Hagiwara, Eiji Mita, Yoshiyuki Kanazawa, Akinori Kasahara, Hideyuki Fusamoto, Takenobu Kamada – 1 August 1995 – Hepatitis C virus (HCV) has been reported to conform to a quasispecies nature, which is most evident in hypervariable regions of the putative envelope 2 domain. The aim of this study was to determine the relationship between the nucleotide complexity and diversity of hypervariable region 1 and various stages of the carrier states.

Loren Laine – 1 August 1995

Paul A. Cahill, Cory Foster, Eileen M. Redmond, Cindy Gingalewski, Yuping Wu, James V. Sitzmann – 1 August 1995 – Portal hypertension (PHT) is characterized by splanchnic hyperemia caused by a reduction in mesenteric vascular resistance. Mediators of this hyperemia include nitric oxide (NO). This is based on several reports indicating a marked splanchnic hyporesponsiveness in PHT to vasoconstrictor stimuli, both in vitro and in vivo, and a subsequent reversal using specific inhibitors of NO synthase (NOS).